Business Model
25%PMI generates durable revenue from addictive nicotine demand across combustibles (58.5% of FY2025 revenue) and smoke-free (41.5%, up from 24.2% in FY2020). Geographic breadth across 180+ markets and five consecutive years of volume growth anchor forward visibility, though product exposure remains concentrated in a single demand category.
Competitive Advantages
40%Brand equity in Marlboro, IQOS, and ZYN supports above-inflation pricing across multiple recent years. IQOS holds about 76% of the global heat-not-burn category on the strength of $14B of smoke-free R&D investment since 2008. Switching costs and network effects are structurally weak for nicotine products.
Full analysis requires login
Sign in to unlock competitive advantages, management quality, risk assessment, and conclusions.
Sign in to continue